Ehsan Mohammad Hosseini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ehsan Mohammad Hosseini has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Hamid Nasrolahi
Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
6 shared publications - Susan Andalibi
Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
6 shared publications - Mansour Ansari
Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
5 shared publications - Arman Sourani
Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications - Keyvan Eghbal
Neurosurgery Department, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications - Mina Foroughi
Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in World Neurosurgery
- Vol. 212, 125138
Microsurgical Clipping of Anterior Communicating Artery Aneurysms in Limited-Resource Setting: A 14-Year Single-Center Surgical Experience
- 19 June 2026
- Published by Elsevier in World Neurosurgery
- Vol. 212, 125138
Open AccessMicrosurgical Clipping of Anterior Communicating Artery Aneurysms in Limited-Resource Setting: A 14-Year Single-Center Surgical Experience
- 28 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-8
Diagnostic accuracy of [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT in differentiating tumor recurrence from post-treatment changes in glioblastoma
Objective This study aimed to evaluate the diagnostic accuracy of [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT in differentiating glioblastoma recurrence from post-treatment changes, comparing both visual and quantitative parameters with follow-up MRI as the reference standard. Methods In this cross-sectional study, 31 lesions with suspected glioblastoma recurrence underwent [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT imaging. PSMA uptake was assessed visually (0: no uptake, 1: mild, 2: moderate, 3: severe) and quantitatively using the tumor-to-background ratio (TBR). Diagnostic performance was evaluated through ROC analysis, sensitivity, specificity, and area under the curve (AUC) comparisons. Results Among the 30 patients with 31 lesions (70% male, mean age 46 years), initial MRI identified recurrence in 38.71% (n = 12), no recurrence in 35.48% (n = 11), and was indeterminate in 25.81% (n = 8) of lesions. Follow-up MRI and other clinical data confirmed recurrence in 58.06% (n = 18) and no recurrence in 41.94% (n = 13). Quantitative SPECT/CT analysis revealed a mean TBR of 13.08 ± 12.09. Visual PSMA assessment demonstrated a sensitivity of 83% and specificity of 92% when considering moderate/high uptake as positive. TBR quantitative analysis showed excellent discrimination (AUC = 0.87), with an optimal threshold of 7.55 yielding 89% sensitivity and 91% specificity. Initial MRI had 100% sensitivity and 91.67% specificity when excluding indeterminate cases. For the 8 patients with indeterminate initial MRI, both visual and quantitative PSMA parameters showed 100% accuracy in predicting the final diagnosis. Conclusion [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT, particularly using quantitative TBR analysis, offers a reliable alternative to MRI for detecting GBM recurrence, especially in cases where MRI findings are equivocal.
- 28 May 2026
- Published by Springer Nature in Neuroradiology
- p. 1-8
Diagnostic accuracy of [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT in differentiating tumor recurrence from post-treatment changes in glioblastoma
Objective This study aimed to evaluate the diagnostic accuracy of [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT in differentiating glioblastoma recurrence from post-treatment changes, comparing both visual and quantitative parameters with follow-up MRI as the reference standard. Methods In this cross-sectional study, 31 lesions with suspected glioblastoma recurrence underwent [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT imaging. PSMA uptake was assessed visually (0: no uptake, 1: mild, 2: moderate, 3: severe) and quantitatively using the tumor-to-background ratio (TBR). Diagnostic performance was evaluated through ROC analysis, sensitivity, specificity, and area under the curve (AUC) comparisons. Results Among the 30 patients with 31 lesions (70% male, mean age 46 years), initial MRI identified recurrence in 38.71% (n = 12), no recurrence in 35.48% (n = 11), and was indeterminate in 25.81% (n = 8) of lesions. Follow-up MRI and other clinical data confirmed recurrence in 58.06% (n = 18) and no recurrence in 41.94% (n = 13). Quantitative SPECT/CT analysis revealed a mean TBR of 13.08 ± 12.09. Visual PSMA assessment demonstrated a sensitivity of 83% and specificity of 92% when considering moderate/high uptake as positive. TBR quantitative analysis showed excellent discrimination (AUC = 0.87), with an optimal threshold of 7.55 yielding 89% sensitivity and 91% specificity. Initial MRI had 100% sensitivity and 91.67% specificity when excluding indeterminate cases. For the 8 patients with indeterminate initial MRI, both visual and quantitative PSMA parameters showed 100% accuracy in predicting the final diagnosis. Conclusion [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT, particularly using quantitative TBR analysis, offers a reliable alternative to MRI for detecting GBM recurrence, especially in cases where MRI findings are equivocal.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2026 (1) , 4460648
Rare Metastatic Involvement of the Sigmoid Mesocolon by Low‐Grade Endometrial Stromal Sarcoma
Introduction: Endometrial stromal sarcoma (ESS) is an uncommon uterine malignancy with an indolent course and potential for late recurrence or metastasis. Extrauterine ESS is exceedingly rare, especially in the absence of a primary uterine lesion. Case Presentation: We present a case of a 50‐year‐old woman with low‐grade ESS metastasizing to the sigmoid mesocolon. The patient underwent surgical resection followed by radical hysterectomy, bilateral salpingo‐oophorectomy, and hormonal therapy with letrozole. After 5 years of follow‐up, she remains disease‐free. Discussion: This case underscores the importance of considering ESS in the differential diagnosis of mesocolon masses and highlights the role of combined surgical and hormonal therapy in achieving long‐term remission.
- 1 January 2026
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2026 (1) , 4460648
Open AccessRare Metastatic Involvement of the Sigmoid Mesocolon by Low‐Grade Endometrial Stromal Sarcoma
Introduction: Endometrial stromal sarcoma (ESS) is an uncommon uterine malignancy with an indolent course and potential for late recurrence or metastasis. Extrauterine ESS is exceedingly rare, especially in the absence of a primary uterine lesion. Case Presentation: We present a case of a 50‐year‐old woman with low‐grade ESS metastasizing to the sigmoid mesocolon. The patient underwent surgical resection followed by radical hysterectomy, bilateral salpingo‐oophorectomy, and hormonal therapy with letrozole. After 5 years of follow‐up, she remains disease‐free. Discussion: This case underscores the importance of considering ESS in the differential diagnosis of mesocolon masses and highlights the role of combined surgical and hormonal therapy in achieving long‐term remission.
- 3 June 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (8) , 3227-3232
Carcinoma Ex Pleomorphic Adenoma of the Maxillary Sinus: Report of Two Cases
Carcinoma ex pleomorphic adenoma (Ca ex PA) is a malignant epithelial salivary gland neoplasm that arises from or within a pleomorphic adenoma. It has been named Carcinoma ex mixed tumor, Carcinoma ex adenoma, and Carcinoma ex benign pleomorphic adenoma. Ca ex PA is rare and accounts for approximately. 3–6% of all salivary gland neoplasms and 11% of all malignant salivary gland tumors. Ca ex PA of the maxillary sinus is rare and has occasionally been reported as part of a large series. The present article reports two cases of maxillary sinus Ca ex PA.
- 3 June 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (8) , 3227-3232
Carcinoma Ex Pleomorphic Adenoma of the Maxillary Sinus: Report of Two Cases
Carcinoma ex pleomorphic adenoma (Ca ex PA) is a malignant epithelial salivary gland neoplasm that arises from or within a pleomorphic adenoma. It has been named Carcinoma ex mixed tumor, Carcinoma ex adenoma, and Carcinoma ex benign pleomorphic adenoma. Ca ex PA is rare and accounts for approximately. 3–6% of all salivary gland neoplasms and 11% of all malignant salivary gland tumors. Ca ex PA of the maxillary sinus is rare and has occasionally been reported as part of a large series. The present article reports two cases of maxillary sinus Ca ex PA.
- Open Access
- 17 March 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (11)
Hybrid endovascular and open surgical management of retained stab wounds: illustrative case
BACKGROUND: Penetrating brain injuries (PBIs) are rare cases of traumatic brain injuries and are associated with high mortality. Initial management for PBIs focuses on airway, circulation, and cranial imaging evaluation. In the next step, physical examinations are essential, including understanding the mechanism of injury, conducting a thorough neurological assessment, and reviewing medications. Imaging techniques such as CT and CT angiography are essential for assessing the extent of the injury and predicting outcomes. OBSERVATIONS: A 30-year-old male presented with a PBI in the left eye. A CT scan revealed that a knife had penetrated into the frontal lobe, causing contusions and subarachnoid hemorrhage. Angiography showed that the knife was close to the anterior cerebral artery (A1–A2 junction), which increased the risk of hemorrhage and complications during removal of the knife. A hybrid approach using angiographic guidance and balloon/stent catheters was used. Incremental removal of the knife was performed with real-time angiographic monitoring. The patient underwent successful skull base repair and enucleation, with follow-up showing no complications. LESSONS: Traditional acute management typically involves craniotomy for foreign object removal; however, this case report highlights the successful application of endovascular techniques alongside the classic method for hybrid management of these patients. https://thejns.org/doi/10.3171/CASE24692
- 17 March 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (11)
Open AccessHybrid endovascular and open surgical management of retained stab wounds: illustrative case
BACKGROUND: Penetrating brain injuries (PBIs) are rare cases of traumatic brain injuries and are associated with high mortality. Initial management for PBIs focuses on airway, circulation, and cranial imaging evaluation. In the next step, physical examinations are essential, including understanding the mechanism of injury, conducting a thorough neurological assessment, and reviewing medications. Imaging techniques such as CT and CT angiography are essential for assessing the extent of the injury and predicting outcomes. OBSERVATIONS: A 30-year-old male presented with a PBI in the left eye. A CT scan revealed that a knife had penetrated into the frontal lobe, causing contusions and subarachnoid hemorrhage. Angiography showed that the knife was close to the anterior cerebral artery (A1–A2 junction), which increased the risk of hemorrhage and complications during removal of the knife. A hybrid approach using angiographic guidance and balloon/stent catheters was used. Incremental removal of the knife was performed with real-time angiographic monitoring. The patient underwent successful skull base repair and enucleation, with follow-up showing no complications. LESSONS: Traditional acute management typically involves craniotomy for foreign object removal; however, this case report highlights the successful application of endovascular techniques alongside the classic method for hybrid management of these patients. https://thejns.org/doi/10.3171/CASE24692
- Open Access
- 19 February 2025
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 24, e7
The efficacy of pomegranate flower on the radiation-induced oral mucositis in the head and neck malignancy: a phase II clinical trial
Introduction: Oral mucositis (OM) emerged in the late 1980s to describe the adverse effects of radiation therapy (RT) on the oral mucosa. OM is the most common and clinically significant acute adverse effect of radiotherapy for head and neck cancer. Symptoms of OM vary from pain and discomfort to an inability to tolerate food or fluids, and it may affect the quality of life, breaks in treatment, hospitalisation, and therefore cancer treatment and outcome. This study aimed to evaluate the pomegranate flower’s efficacy in preventing and treating radiation-induced mucositis due to antioxidant, anti-inflammatory and anti-cancer effects. Methods and materials: This phase II clinical trial was conducted on 50 patients (case and control) with head and neck malignancy. Patients in the case groups were instructed to rinse their mouths with 5 mg Pomegranate powder with 15 cc of sterile water three times a day. The patients in the control group rinsed their mouths with normal saline mouthwash, which is the most relatively accepted preventive and supportive care in this setting. The onset and degree of radiation-induced mucositis were graded during treatment, with ‘WHO mucositis grading’ and the ‘quality of life questionnaire’ (QLQ-OES18). Result: Forty-eight patients were analysed. There was a significant difference between the two groups on onset and severity of mucositis in the two groups. There were longer intervals for the incidence of different grades of mucositis in the case group, in comparison with the control groups (P value < 0·05). Also, Complaints of dysphagia in the case groups were lower than in the control. Conclusion: Pomegranate flower seems to be effective at the time of onset, and the severity of oral mucositis during head and neck radiation. It could be a simple, potent, and inexpensive agent, which is easily available.
- 19 February 2025
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 24, e7
Open AccessThe efficacy of pomegranate flower on the radiation-induced oral mucositis in the head and neck malignancy: a phase II clinical trial
Introduction: Oral mucositis (OM) emerged in the late 1980s to describe the adverse effects of radiation therapy (RT) on the oral mucosa. OM is the most common and clinically significant acute adverse effect of radiotherapy for head and neck cancer. Symptoms of OM vary from pain and discomfort to an inability to tolerate food or fluids, and it may affect the quality of life, breaks in treatment, hospitalisation, and therefore cancer treatment and outcome. This study aimed to evaluate the pomegranate flower’s efficacy in preventing and treating radiation-induced mucositis due to antioxidant, anti-inflammatory and anti-cancer effects. Methods and materials: This phase II clinical trial was conducted on 50 patients (case and control) with head and neck malignancy. Patients in the case groups were instructed to rinse their mouths with 5 mg Pomegranate powder with 15 cc of sterile water three times a day. The patients in the control group rinsed their mouths with normal saline mouthwash, which is the most relatively accepted preventive and supportive care in this setting. The onset and degree of radiation-induced mucositis were graded during treatment, with ‘WHO mucositis grading’ and the ‘quality of life questionnaire’ (QLQ-OES18). Result: Forty-eight patients were analysed. There was a significant difference between the two groups on onset and severity of mucositis in the two groups. There were longer intervals for the incidence of different grades of mucositis in the case group, in comparison with the control groups (P value < 0·05). Also, Complaints of dysphagia in the case groups were lower than in the control. Conclusion: Pomegranate flower seems to be effective at the time of onset, and the severity of oral mucositis during head and neck radiation. It could be a simple, potent, and inexpensive agent, which is easily available.
- Open Access
- 13 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70206
Salvage En Bloc Resection for Refractory Recurrent Pure Testicular Seminoma: A Case Report
Treating recurrent or cisplatin‐refractory germ cell tumors remains a clinically problematic situation. Although testicular cancer has a good overall cure rate, some patients with metastatic GCTs who did not respond to initial treatments have few therapeutic alternatives and face significant fatality rates. This case showed the successful implementation of radical surgery for patients with refractory seminoma in clinical practice.
- 13 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70206
Open AccessSalvage En Bloc Resection for Refractory Recurrent Pure Testicular Seminoma: A Case Report
Treating recurrent or cisplatin‐refractory germ cell tumors remains a clinically problematic situation. Although testicular cancer has a good overall cure rate, some patients with metastatic GCTs who did not respond to initial treatments have few therapeutic alternatives and face significant fatality rates. This case showed the successful implementation of radical surgery for patients with refractory seminoma in clinical practice.
- Open Access
- 7 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123654
Microsurgical Clipping of Blood Blister-like Anterior Communicating Artery Aneurysm in a Patient with Total Occlusion of Left Internal Carotid Artery Aneurysm
- 7 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123654
Open AccessMicrosurgical Clipping of Blood Blister-like Anterior Communicating Artery Aneurysm in a Patient with Total Occlusion of Left Internal Carotid Artery Aneurysm
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2025 (1) , 2302217
Guardians of Sensation: Evaluating Metformin’s Power Against Chemotherapy‐Induced Neuropathy
Background: Chemotherapy‐induced peripheral neuropathy (CIPN) is a common and debilitating complication of cancer treatment, particularly with agents like paclitaxel. Effective preventive measures for CIPN are limited. Metformin, an antihyperglycemic agent with neuroprotective properties, has shown promise in preclinical studies; however, its clinical utility in preventing CIPN remains underexplored. Objective: This study evaluates the preventive effects of metformin on paclitaxel‐induced peripheral neuropathy in breast cancer patients. Methods: A randomized, controlled study was conducted involving 60 breast cancer patients receiving paclitaxel chemotherapy. Patients were assigned to an intervention group receiving metformin (500 mg twice daily) or a control group without metformin. Peripheral nerve function was assessed using nerve conduction studies (NCSs), measuring sensory nerve action potential (SNAP) amplitude, compound muscle action potential (CMAP) amplitude, and distal latency (DL). Clinical neurological symptoms and adverse effects of metformin were monitored throughout the study. Results: Of the 60 enrolled patients, 47 completed the study (26 control and 21 intervention). The incidence of CIPN was lower in the metformin group compared to the control group, although this difference did not reach statistical significance. Metformin was well‐tolerated, with mild gastrointestinal side effects being the most common adverse events. No significant differences between the groups were observed in SNAP amplitude, CMAP amplitude, or DL. Conclusion: Metformin may modestly reduce the incidence of CIPN in patients receiving paclitaxel chemotherapy, although the observed effect was not statistically significant. Given its safety profile and potential neuroprotective benefits, metformin warrants further investigation in larger, multicenter trials to confirm its role in CIPN prevention.
- 1 January 2025
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2025 (1) , 2302217
Open AccessGuardians of Sensation: Evaluating Metformin’s Power Against Chemotherapy‐Induced Neuropathy
Background: Chemotherapy‐induced peripheral neuropathy (CIPN) is a common and debilitating complication of cancer treatment, particularly with agents like paclitaxel. Effective preventive measures for CIPN are limited. Metformin, an antihyperglycemic agent with neuroprotective properties, has shown promise in preclinical studies; however, its clinical utility in preventing CIPN remains underexplored. Objective: This study evaluates the preventive effects of metformin on paclitaxel‐induced peripheral neuropathy in breast cancer patients. Methods: A randomized, controlled study was conducted involving 60 breast cancer patients receiving paclitaxel chemotherapy. Patients were assigned to an intervention group receiving metformin (500 mg twice daily) or a control group without metformin. Peripheral nerve function was assessed using nerve conduction studies (NCSs), measuring sensory nerve action potential (SNAP) amplitude, compound muscle action potential (CMAP) amplitude, and distal latency (DL). Clinical neurological symptoms and adverse effects of metformin were monitored throughout the study. Results: Of the 60 enrolled patients, 47 completed the study (26 control and 21 intervention). The incidence of CIPN was lower in the metformin group compared to the control group, although this difference did not reach statistical significance. Metformin was well‐tolerated, with mild gastrointestinal side effects being the most common adverse events. No significant differences between the groups were observed in SNAP amplitude, CMAP amplitude, or DL. Conclusion: Metformin may modestly reduce the incidence of CIPN in patients receiving paclitaxel chemotherapy, although the observed effect was not statistically significant. Given its safety profile and potential neuroprotective benefits, metformin warrants further investigation in larger, multicenter trials to confirm its role in CIPN prevention.
- Open Access
- 1 September 2024
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 15 (5) , 649-658
The Optimal Time for Postoperative Magnetic Resonance Imaging of the Sella in Patients With Pituitary Adenoma
Introduction: Magnetic resonance imaging (MRI) is the preferred neuroradiologic tool for evaluating the sellar region. Pituitary adenomas account for about 15% of primary intracranial tumors. The optimal time for postoperative MRI of central nervous system neoplasms is 48 hours after surgery. Nevertheless, controversy exists regarding the timing of postoperative MRI ...
- 1 September 2024
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 15 (5) , 649-658
Open AccessThe Optimal Time for Postoperative Magnetic Resonance Imaging of the Sella in Patients With Pituitary Adenoma
Introduction: Magnetic resonance imaging (MRI) is the preferred neuroradiologic tool for evaluating the sellar region. Pituitary adenomas account for about 15% of primary intracranial tumors. The optimal time for postoperative MRI of central nervous system neoplasms is 48 hours after surgery. Nevertheless, controversy exists regarding the timing of postoperative MRI ...